Physiology, production and action of progesterone

Acta Obstetricia et Gynecologica Scandinavica

Volumn 94, Issue , 2015, Pages 8-16

  Taraborrelli, Stefania ^a  

^a GynePro Medical Centers   (Italy)

Author keywords

genomic and nongenomic action; progesterone effects; Progesterone synthesis; window of implantation

Indexed keywords

PROGESTERONE; PROGESTERONE RECEPTOR A; PROGESTERONE RECEPTOR B; PROGESTERONE RECEPTOR;

CENTRAL NERVOUS SYSTEM; DRUG EFFECT; HORMONE SYNTHESIS; HUMAN; MAMMARY GLAND; MENSTRUAL CYCLE; NIDATION; NONHUMAN; OSTEOPOROSIS; OVARY CYCLE; PREGNANCY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; STEROIDOGENESIS; TARGET ORGAN; CELL MEMBRANE; CELL NUCLEUS; ENDOMETRIUM; FEMALE; METABOLISM; PHYSIOLOGY;

CELL MEMBRANE; CELL NUCLEUS; CENTRAL NERVOUS SYSTEM; EMBRYO IMPLANTATION; ENDOMETRIUM; FEMALE; HUMANS; MAMMARY GLANDS, HUMAN; MENSTRUAL CYCLE; OSTEOPOROSIS; PROGESTERONE; RECEPTORS, PROGESTERONE;

EID: 84947252066     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1111/aogs.12771     Document Type: Review

References (67)

1. Stefanick ML. Estrogens and progestins: background and history, trends in use, and guidelines and regimens approved by the US Food and Drug Administration. Am J Med. 2005;118:64S-73S
2. Birch AJ. Hydro aromatic steroid hormones. Part I. 10-Nortestosterone. J Chem. Soc., 1950, 367-368 DOI: 10.1039/JR9500000367
3. Sandor T, Mehdi AZ. Steroids and evolution. In: Barrington EJW (ed). Hormones and Evolution. New York: Academic Press, 1979. pp. 1-72
4. Genazzani AR (ed). Endocrinologia ginecologica. Editeam, Cento (FE), Italy. 2004;1-464
5. Andersen JM, Dietschy JM. Relative importance of high and low density lipoproteins in the regulation of cholesterol synthesis in the adrenal gland, ovary and testis in the rat. J Biol Chem. 1978;253:9024-6
6. Brown MS, Goldstein JL. Receptor-mediated control of cholesterol metabolism. Science. 1976;191:150-5
7. Amadori A, Cavallari C, Giacomucci E, Macrelli S, Mastronuzzi G, Ucci N. (eds). Fisiologia della Riproduzione. Bologna: CLUEB, 1994;1-192
8. Ryan KJ, Petro Z, Kaiser J. Steroid formation by isolated and recombined granulosa and thecal cells. J Clin Endocrinol Metab. 1968;28:355-60
9. Kobayashi M, Nakano R, Ooshima A. Immunohistochemical localization of pituitary gonadotropins and gonadal steroids confirms the "two-cell, two-gonadotrophin" hypothesis of steroidogenesis in the human ovary. J Endocrinol. 1990;126:483-8
10. Peluso JJ. Progesterone receptor membrane component 1 and its role in ovarian follicle growth. Front Neurosci. 2013;10:3389-95
11. Frederick JL, Shimanuki T, diZerega GS. Initiation of angiogenesis by human follicular fluid. Science. 1984;224:389-90
12. Revindranath N, Little-Ihrig L, Benyo DF, Zeleznik AJ. Role of LH in the expression of cholesterol side-chaincleavage Cit P-450 and 3 a-hydroxy dehydrogenase isomerase messenger ribonucleic acids in the primate corpus luteum. Endocrinol. 1992;131:2065-8
13. Filicori M, Butler JP, Crowley WF Jr. Neuroendocrine regulation of the corpus luteum in the human. Evidences for pulsatile gonadotropin secretion. J Clin Endocrinol. 1984;73:1638-47
14. Lessey BA, Killam AP, Metzger DA, Haney AF, Greene GL, McCarty KS Jr. Immunohistochemical analysis of human uterine estrogen and progesterone receptors throughout the menstrual cycle. J Clin Metabol. 1988;67:334-8
15. Satyaswaroop PG, Wartell DJ, Mortel R. Distribution of progesterone receptor, estradiol dehydrogenase and 20 alpha-dihydroprogesterone dehydrogenase activities in human endometrial glands and stroma: progestin induction of steroid dehydrogenase activities in vitro is restricted to the glandular epithelium. Endocrinology. 1982;111:743-9
16. The Writing Group for the PEPI Trial. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/ Progestin Interventions (PEPI) Trial. JAMA. 1996;275:370-5
17. Csapo AL, Pukkinen MO. Effects of luteectomy and progesterone replacement in early pregnant patients. Am J Obstet Gynecol. 1973;115:759-64
18. Schneider MA, Davies MC, Honour JW. The timing of placental competence in pregnancy after oocyte donation. Fertil Steril. 1993;59:1059-63
19. Parker MG, Christian M, White R. The nuclear receptor co-repressor RIP140 controls the expression of metabolic gene network. Biochem Soc Trans. 2006;34:1103-6
20. Lonard DM, Lanz RB, O'Malley BW. Nuclear receptor coregulators and human disease. Endocr Rev. 2008;28:575-87
21. Gellersen B, Fernandes MS, Brosens JJ. Non genomic progesterone actions in female reproduction. Human Reprod Update. 2009;15:119-38
22. Kastner P, Krust A, Turcotte B, Stropp U, Tora L, Gronemeyer H, et al. Two distinct estrogen-regulated promoters generate transcripts endcoding the two functionally different human progesterone receptor forms A and B. EMBO J. 1990;9:1603-14
23. Condon JC, Hardy DB, Kovaric K, Mendelson CR. Upregulation of the progesterone receptor C isoform in laboring myometrium by activation of nuclear factor B may contribute to the onset of labor through inhibition of PR function. Mol Endocrinol. 2006;20:764-75
24. Fu X, Simoncini T. Non genomic sex steroid actions in the vascular system. Semin Reprod Med. 2007;25:178-86
25. Revelli A. Non genomic actions of steroid hormones in reproductive tissues. Endocrin Rev. 1998;19:3-17
26. Peluso JJ, Pappalardo A, Fernandez G, Wu CA. Involvement of an unnamed protein, RDA288, in the mechanism through which progesterone mediates its antiapoptotic action in spontaneously immortalized granulosa cells. Endocrinol. 2004;145:3014-22
27. Koensgen D, Mustea A, Klaman I, Sun P, Zafrakas M, Lichtenegger W, et al. Expression analysis and RNA localization of PAI RBP1 (SERBP1) in epithelial ovarian cancer association with tumor progression. Gynecol Oncol. 2007;107:266-73
28. Bolvin G, Anthoine-Terrier C, Morel G. Ultrasound of endogenous hormones and receptors in bone tissue: an immunocytological approach in frozen sections. Micron. 1994;25:15-27
29. Greenberg C, Kukreja SC, Bowser EN, Hargis GK, Henderson WJ, Williams GA. Effects of estradiol and progesterone on calcitonin secretion. Endocrinology. 1996;118:2594-8
30. Delmas PD. A combination of low dose of 17 beta estradiol and norethisterone acetato prevents bone loss and normalizes bone turnover in postmenopausal women. Osteoporos Int. 2000;11:177-87
31. Wren BG. Transdermal progesterone and its effects on vasomotor symptoms, blood lipid levels, bone metabolic markers, moods, and quality of life for postmenopausal women. Menopause. 2003;10:13-8
32. Yao W, Dai W, Shahnazari M, Pham A, Chen Z, Chen H, et al. Inhibition of the progesterone nuclear receptor during the bone linear growth phase increases peak bone mass in female mice. PLoS ONE. 2010;5:e11410
33. Goodman RL, Karsch FJ. Pulsatile secretion of LH: differential suppression by ovarian steroids. Endocrinology. 1980;107:1286-90
34. Sayeed I. Progesterone is neuroprotective factor in traumatic and ischemic brain injury. Prog Brain Res. 2009;175:219-37
35. Wang JM. Regeneration in a degenerating brain: potential of allopregnagnolone as a neuroregenerative agent. Curr Alzheimer Res. 2007;4:510-7
36. Pinna G, Agis-Balboa RC, Pibiri F, Nelson M, Guidotti A, Costa E. Neurosteroid byosinthesis regulates sexually dimorphic fear and aggressive behavior in mice. Neurochem Res. 2008;33:1990-2007
37. Ziomkiewicz A1, Pawlowski B, Ellison PT, Lipson SF, Thune I, Jasienska G. Higher luteal progesterone is associated with low levels of premenstrual aggressive behavior and fatigue. Biol Psychol. 2012;91:376-82
38. Kaore SN, Langade DK, Yadav VK, Sharma P, Thawani VR, Sharma R. Novel actions of progesterone: what we know today and what will be the scenario in the future? J Pharm Pharmacol. 2012;64:1040-62
39. Meyer L, Patte-Mensah C, Taleb O, Mensah-Nyagan AG. Cellular and functional evidence for a protective action of neurosteroids against vincristine chemotherapy-induced painful neuropathy. Cell Mol Life Sci. 2010;67:3017-34
40. De Lignieres B. Estradiol and progesterone regulate the proliferation of human breast epithelial cells. Fertil Steril. 1998;69:963-9
41. Fournier A, Berrino F, Clavel-Chapelon F. Unequal risks for breast cancer associated with different hormone replacement therapies: results from E3N cohort study. Breast Cancer Res. 2008;107:103-11
42. Wharton W, Gleason CE, Miller VM, Asthana S. Rationale and design of the KEEPS and the KEEPS Cognitive and affective sub study. Brain Res. 2013;1514:12-7
43. Mirkin S, Amadio JM, Bernick BA, Pickar JH, Archer DF. 17 b-estradiol and natural progesterone for menopausal hormone therapy: REPLENISH phase 3 study design of combination capsule and evidence review. Maturitas. 2015;81:28-35
44. Luconi M, Francavilla F, Porazzi I, Macerola B, Forti G, Baldi E. Human spermatozoa as a model for studying membrane receptors mediating rapid nongenomic effects of progesterone and estrogens. Steroids. 2004;69:553-9
45. Blackmore PF, Neulen J, Lattanzio F, Beebe SJ. Cell surface-binding sites for progesterone mediate calcium uptake in human sperm. J Biol Chem. 1991;266:18655-9
46. Kirkman-Brown JC, Bray C, Stewart PM, Barratt CL, Publicover SJ. Biphasic elevation of [Ca2+]i in individual human spermatozoa exposed to progesterone. Dev Biol. 2000;222:326-35
47. Maller JL. The elusive progesterone receptor in Xenopus oocytes. Proc Natl Acad Sci USA. 2001;98:8-10
48. Bagowski CP, Myers JW, Ferrell JE Jr. The classical progesterone receptor associates with p42 MAPK and is involved in phosphatidylinositol 3-kinase signaling in Xenopus oocytes. J Biol Chem. 2001;276:37708-14
49. Dosiou C, Hamilton AE, Pang Y, Overgaard MT, Tulac S, Dong J, et al. Expression of membrane progesterone receptors on human T lymphocytes and Jurkat cells and activation of G-proteins by progesterone. J Endocrinol. 2008;196:67-77
50. Ehring GR, Kerschbaum HH, Eder C, Neben AL, Fanger CM, Khoury RM, et al. A nongenomic mechanism for progesterone-mediated immunosuppression: inhibition of K+ channels, Ca2+ signaling, and gene expression in T lymphocytes. J Exp Med. 1998;188:1593-602
51. Bar J, Lahav J, Hod M, Ben-Rafael Z, Weinberger I, Brosens J. Regulation of platelet aggregation and adenosine triphosphate release in vitro by 17b-estradiol and medroxyprogesterone acetate in postmenopausal women. Thromb Haemost. 2000;84:695-700
52. Blackmore PF, Fisher JF, Spilman CH, Bleasdale JE. Unusual steroid specificity of the cell surface progesterone receptor on human sperm. Mol Pharmacol. 1996;49:727-39
53. Blackmore PF. Progesterone metabolites rapidly stimulate calcium influx in human platelets by a src-dependent pathway. Steroids. 2008;73:738-50
54. Peluso JJ, Pappalardo A. Progesterone regulates granulosa cell viability through a protein kinase G-dependent mechanism that may involve 14-3-3s. Biol Reprod. 2004;71:1870-8
55. Peluso JJ, Fernandez G, Pappalardo A, White BA. Characterization of a putative membrane receptor for progesterone in rat granulosa cells. Biol Reprod. 2001;65:94-101
56. Bielefeldt K, Waite L, Abboud FM, Conklin JL. Nongenomic effects of progesterone on human intestinal smooth muscle cells. Am J Physiol. 1996;271:G370-6
57. Barbagallo M, Dominguez LJ, Licata G, Shan J, Bing L, Karpinski E, et al. Vascular effects of progesterone: role of cellular calcium regulation. Hypertension. 2001;37:142-7
58. Rossato M, Nogara A, Merico M, Ferlin A, Foresta C. Identification of functional binding sites for progesterone in rat Leydig cell plasma membrane. Steroids. 1999;64:168-75
59. El-Hefnawy T, Huhtaniemi I. Progesterone can participate in downregulation of the luteinizing hormone receptor gene expression and function in cultured murine Leydig cells. Mol Cell Endocrinol. 1998;137:127-38
60. Frye CA, Sumida K, Lydon JP, O'Malley BW, Pfaff DW. Mid-aged and aged wild-type and progestin receptor knockout (PRKO) mice demonstrate rapid progesterone and 3a,5a-THP-facilitated lordosis. Psychopharmacology. 2006;185:423-32
61. Verikouki CH, Hatzoglou CH, Gourgoulianis KI, Molyvdas PA, Kallitsaris A, Messinis IE. Rapid effect of progesterone on transepithelial resistance of human fetal membranes: evidence for non-genomic action. Clin Exp Pharmacol Physiol. 2008;35:174-9
62. Fu XD, Flamini M, Sanchez AM, Goglia L, Giretti MS, Genazzani AR, et al. Progestogens regulate endothelial actin cytoskeleton and cell movement via the actin-binding protein moesin. Mol Hum Reprod. 2008a;14:225-34
63. Fu XD, Giretti MS, Baldacci C, Garibaldi S, Flamini M, Sanchez AM, et al. Extra-nuclear signaling of progesterone receptor to breast cancer cell movement and invasion through the actin cytoskeleton. PLoS ONE. 2008b;3:e2790
64. Kaur P, Jodhka PK, Underwood WA, Bowles CA, de Fiebre NC, de Fiebre CM, et al. Progesterone increases brain-derived neuroptrophic factor expression and protects against glutamate toxicity in a mitogen-activated protein kinase- and phosphoinositide-3 kinase-dependent manner in cerebral cortical explants. J Neurosci Res. 2007;85:2441-9
65. Nilsen J, Brinton RD. Divergent impact of progesterone and medroxyprogesterone acetate (Provera) on nuclear mitogenactivated protein kinase signaling. Proc Natl Acad Sci USA. 2003;100:10506-11
66. Cai W, Zhu Y, Furuya K, Li Z, Sokabe M, Chen L. Two different molecular mechanisms underlying progesterone neuroprotection against ischemic brain damage. Neuropharmacology. 2008;55:127-38
67. Koulen P, Madry C, Duncan RS, Hwang JY, Nixon E, McClung N, et al. Progesterone potentiates IP3-mediated calcium signaling through Akt/PKB. Cell Physiol Biochem. 2008;21:161-72